Treatment with neurohormonal inhibitors and prognostic outcome in pulmonary arterial hypertension with risk factors for left heart disease

BACKGROUND: Despite major advances in pharmacologic treatment, patients with pulmonary arterial hypertension (PAH) still have a considerably reduced life expectancy. In this context, chronic hyperactivity of the neurohormonal axis has been shown to be detrimental in PAH, thus providing novel insight...

Descripción completa

Detalles Bibliográficos
Autores principales: Scagliola, Riccardo, Brunelli, Claudio, Balbi, Manrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968482/
https://www.ncbi.nlm.nih.gov/pubmed/35433314
http://dx.doi.org/10.5492/wjccm.v11.i2.85

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968482/
https://www.ncbi.nlm.nih.gov/pubmed/35433314
http://dx.doi.org/10.5492/wjccm.v11.i2.85

Ejemplares similares